MelioLabs, Inc.
Biotechnology company · Santa Clara, California, United States
MelioLabs, Inc. is a biotechnology company headquartered in Santa Clara, California, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $599,625 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2024.
MelioLabs at a glance
What does MelioLabs do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $599,625 in total (2019 to 2022). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $4 million sold (2024).
Frequently asked questions about MelioLabs
Where is MelioLabs headquartered?
MelioLabs, Inc. is headquartered in Santa Clara, California, United States.
What does MelioLabs do?
MelioLabs, Inc. is a biotechnology company.
When was MelioLabs founded?
The earliest incorporation on record for MelioLabs, Inc. is in 2018, according to public company registers.
Similar companies
- Invicta Medical, Inc.Santa Clara, California, United States
- Cytobank, Inc.Santa Clara, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences